SCHEMBL6095918

SCHEMBL6095918

CC1(c2[nH]c3ccccc3c2C2=C(O)C(=O)C=C(O)C2=O)CCCCC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.38
ALDH1A1 P00352 2/20 0.38
MAPT P10636 4/20 0.37
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
CRHBP P24387 1/20 0.37
MAPK1 P28482 1/20 0.37
CRHR2 Q13324 1/20 0.37
OPRM1 P35372 2/20 0.35
LMNA P02545 3/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
NPC1 O15118 3/20 0.34
RAB9A P51151 3/20 0.34
KDM4E B2RXH2 2/20 0.34
POLB P06746 2/20 0.34
NLRP3 Q96P20 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
PADI4 Q9UM07 1/20 0.33
CCR6 P51684 1/20 0.33
HKDC1 Q2TB90 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6096623 0.94 ALDH1A1 (0.39) TSHRALDH1A1MAPTMEN1KMT2A
SCHEMBL6097015 0.79 MAPT (0.34) TSHRALDH1A1MAPTMEN1KMT2A
SCHEMBL6110147 0.78 CCR6 (0.51) ALDH1A1MAPTMEN1KMT2ALMNA
SCHEMBL6093878 0.75 PTPRC (0.54) ALDH1A1MAPTMEN1KMT2AKDM4E
SCHEMBL6096689 0.75 HPGD (0.40) ALDH1A1MAPTMEN1KMT2AMAPK1
SCHEMBL6095875 0.75 XIAP (0.41) ALDH1A1MAPTMEN1KMT2ALMNA
SCHEMBL6094612 0.75 KDM4E (0.40) ALDH1A1MAPTMEN1KMT2AMAPK1
SCHEMBL6094828 0.74 NPC1 (0.38) TSHRALDH1A1MAPTMEN1KMT2A
SCHEMBL6096197 0.72 OPRM1 (0.35) TSHRALDH1A1MAPTMEN1KMT2A
SCHEMBL8601530 0.70 MEN1 (0.39) ALDH1A1MAPTMEN1KMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7057052-B2 Heterocyclic quinones as pharmaceutical agents DUKE UNIVERSITY (US) 2006-06-06 US disclosed
WO-2004050014-A2 SETEROCYCLIC QUINONES AS PHARMACEUTICAL AGENTS DUKE UNIVERSITY (US) 2004-06-17 WO disclosed
US-20040063774-A1 Heterocyclic quinones as pharmaceutical agents DUKE UNIVERSITY 2004-04-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040063774-A1 Heterocyclic quinones as pharmaceutical agents NQO1, RECQL, SDHA TSHR 4718/4885ALDH1A1 609/4885MAPT 116/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.